Rosiglitazone: opening Pandora's black box?
Gilbert
Richard E
RE
Department of Medicine, St. Michael's Hospital, 61 Queen Street, Toronto, Ontario, Canada, M5C 2T2. richard.gilbert@utoronto.ca
D003928:Diabetic Nephropathies / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009203:Myocardial Infarction / Q000139:chemically induced*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone